Agomelatine: A novel melatonergic antidepressant.

Article Details

Citation

Copy to clipboard

Manikandan S

Agomelatine: A novel melatonergic antidepressant.

J Pharmacol Pharmacother. 2010 Jul;1(2):122-3. doi: 10.4103/0976-500X.72369.

PubMed ID

21350627 [ View in PubMed

]

Abstract

Not Available

DrugBank Data that Cites this Article

Drug Enzymes

Drug	Enzyme	Kind	Organism	Pharmacological Action	Actions
Agomelatine	Cytochrome P450 1A2	Protein	Humans	Unknown	Substrate	Details

Drug Interactions

• Approved
• Vet approved
• Nutraceutical
• Illicit
• Withdrawn
• Investigational
• Experimental
• All Drugs

Drugs	Interaction
Integrate drug-drug interactions in your software
Agomelatine Fluvoxamine	The serum concentration of Agomelatine can be increased when it is combined with Fluvoxamine.
Agomelatine Enoxacin	The serum concentration of Agomelatine can be increased when it is combined with Enoxacin.
Agomelatine Rofecoxib	The serum concentration of Agomelatine can be increased when it is combined with Rofecoxib.
Agomelatine Ciprofloxacin	The serum concentration of Agomelatine can be increased when it is combined with Ciprofloxacin.
Agomelatine Quinidine	The serum concentration of Agomelatine can be increased when it is combined with Quinidine.